Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
Recruiting · NCT06809686 · Observational (researchers observe without assigning treatment) · Lead sponsor: Richmond Research Institute
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
Who can take part
Age range
45 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent.
- Diagnosed with heart failure.
- Able and willing to provide informed consent to participate.
Exclusion criteria
- Diagnostic test results positive for:
- HIV-1 or HIV-2 infection
- Hepatitis B or Hepatitis C infection
- Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.
- Any condition judged by the Investigator to pose an undue risk while participating in the trial
- Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.
Where it is running
2 locations listed.
- Richmond Pharmacology - London, London, United Kingdom
- Richmond Pharmacology - London, London, United Kingdom